Katharine Sinha

Katharine Sinha has extensive work experience in regulatory affairs and consultancy, spanning over two decades. Their most recent position is Director of Regulatory Affairs at Adaptimmune since May 2022. Prior to that, they worked as a Principal Regulatory Consultant at DLRC Regulatory Consultancy from March 2021 to April 2022. Katharine also served as a Regulatory Affairs Consultant at Janssen Inc. from April 2018 to March 2021. Throughout their career, they have held various positions in regulatory affairs, including roles at Reading, Besins Healthcare, Circassia, Premier Research, Aptiv Solutions/SRA GCD/Constella/Origin, and PRA International. Their expertise and knowledge in regulatory affairs make their a valuable asset in the field.

Katharine Sinha obtained their Doctor of Philosophy (Ph.D.) in Malaria from the National Institute for Medical Research (NIMR) in Mill Hill, London, UK. Katharine completed this degree between the years 1989 and 1992.